Synapse - Intensified mycophenolate mofetil (MMF) dosing is safe from the standpoint of engraftment and reduces severe acute graft-versus-host disease (aGVHD) after double-unit cord blood transplantation (DCBT): An analysis of 173 patients

Intensified mycophenolate mofetil (MMF) dosing is safe from the standpoint of engraftment and reduces severe acute graft-versus-host disease (aGVHD) after double-unit cord blood transplantation (DCBT): An analysis of 173 patients Meeting Abstract

Authors:	Ponce, D. M.; Harnicar, S.; Hilden, P.; Devlin, S.; Evans, K.; Lubin, M.; Kernan, N.; Prockop, S. E.; Scaradavou, A.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.
Abstract Title:	Intensified mycophenolate mofetil (MMF) dosing is safe from the standpoint of engraftment and reduces severe acute graft-versus-host disease (aGVHD) after double-unit cord blood transplantation (DCBT): An analysis of 173 patients
Meeting Title:	2014 BMT Tandem Meetings
Journal Title:	Biology of Blood and Marrow Transplantation
Volume:	20
Issue:	2 Suppl. 1
Meeting Dates:	2014 Feb 26-Mar 2
Meeting Location:	Grapevine, TX
ISSN:	1083-8791
Publisher:	Elsevier Inc.
Date Published:	2014-02-01
Start Page:	S279
End Page:	S280
Language:	English
ACCESSION:	WOS:000331155400439
PROVIDER:	wos
DOI:	10.1016/j.bbmt.2013.12.469
Notes:	Poster Session II; Meeting Abstract: 434 -- BMT Tandem Meetings -- FEB 26-MAR 02, 2014 -- Grapevine, TX -- 1 -- Source: Wos